19-41004161-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000767.5(CYP2B6):c.332A>G(p.Tyr111Cys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000344 in 958,204 control chromosomes in the GnomAD database, with no homozygous occurrence. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000767.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2B6 | ENST00000324071.10 | c.332A>G | p.Tyr111Cys | missense_variant, splice_region_variant | Exon 2 of 9 | 1 | NM_000767.5 | ENSP00000324648.2 | ||
CYP2B6 | ENST00000593831.1 | c.104A>G | p.Tyr35Cys | missense_variant, splice_region_variant | Exon 1 of 5 | 2 | ENSP00000470582.1 | |||
CYP2B6 | ENST00000598834.2 | n.233A>G | splice_region_variant, non_coding_transcript_exon_variant | Exon 2 of 10 | 5 | ENSP00000496294.1 | ||||
CYP2B6 | ENST00000594187.1 | n.-218A>G | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000184 AC: 2AN: 108522Hom.: 0 Cov.: 25
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250682Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135656
GnomAD4 exome AF: 0.0000365 AC: 31AN: 849682Hom.: 0 Cov.: 36 AF XY: 0.0000278 AC XY: 12AN XY: 430934
GnomAD4 genome AF: 0.0000184 AC: 2AN: 108522Hom.: 0 Cov.: 25 AF XY: 0.0000203 AC XY: 1AN XY: 49218
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.332A>G (p.Y111C) alteration is located in exon 2 (coding exon 2) of the CYP2B6 gene. This alteration results from a A to G substitution at nucleotide position 332, causing the tyrosine (Y) at amino acid position 111 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at